Dr. Sridevi Juvvadi, M.D.

Media Releases

Get to know Hematologist-Oncologist Dr. Sridevi Juvvadi, who serves patients in Texas.

Dr. Juvvadi is a board-certified hematologist-oncologist with over two decades of experience. In affiliation with Texas Oncology, she practices at Texas Oncology-Irving & Texas Oncology-Medical City Dallas Building C.

Texas Oncology was founded in 1986 by a forward thinking group of physicians who shared a vision to chart their own course. They believed there was a better way to provide cancer care. Together, they made community-based cancer treatment a reality.

The mission of Texas Oncology is to provide excellent, evidence-based care for each patient served, while advancing cancer care for tomorrow.

Educated in India, Dr. Juvvadi completed her pre-medical education at Saint Francis Junior College in Hyderabad, and received her medical degree from Osmania Medical College in 1992, where she also completed her internship. She then relocated to the United States, completing her residency in internal medicine at Saint Barnabas Medical Center in Livingston, New Jersey in 1998, where she was the recipient of the Best Resident Award.

Thereafter, in 2001, Dr. Juvvadi completed her fellowship in medical oncology at Robertwood Johnson Hospital in New Brunswick. There, she was Chief Fellow and received the Motilinsky Award, which is given to the Best Fellow each year in the Hematology/Medical Oncology Division. 

With an unwavering commitment to her specialty, the doctor is board-certified in hematology and medical oncology by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Among her professional affiliations, Dr. Juvvadi is an active member of the American Society of Hematology, the American Society of Clinical Oncology and Hematology, the American College of Physicians, the Dallas County Medical Society, and the American Medical Association.

Prior to joining Texas Oncology, she was in private practice in Dallas.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia, and lymphoma. 

An authority in her field, Dr. Juvvadi has been the recipient of Compassionate Doctor Recognition (2018, 2015), On-Time Doctor Award (2018, 2016), and Patients’ Choice Award (2018).

Happily married, she has one son. Her special interests are local community affairs and charitable work.

Recommended Articles

• Lymphoma News: Mother Gives Birth to Healthy Daughter after Chemo During Pregnancy

  Chemotherapy has a reputation for its not-so-great side effects. As many people know, chemotherapy is known to cause off target symptoms for most cancer patients such as nausea and vomiting, hair loss, and extreme fatigue. In addition to the symptoms that one may experience during treatment, some of...

• John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society

  Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...

• Inspirational Blood Cancer Survivors

  Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...

• Promising Results for Hodgkin Patients Using This Therapy

  Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...

• Survey Shows Lack of Blood Cancer Knowledge Among Americans

  If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...

• New Study Discovers How Lymphoma Affects Survivors’ Ability to Work

  Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...